Literature DB >> 24866797

Development and characterization of a long-term murine model of Streptococcus pneumoniae infection of the lower airways.

Louise Haste1, Kathryn Hulland1, Sarah Bolton2, Hasan Yesilkaya1, Kenneth McKechnie3, Peter W Andrew4.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by long periods of stable symptoms, but exacerbations occur, which result in a permanent worsening of symptoms. Previous studies have shown a link between bacterial colonization of the lower airways of COPD sufferers and an increase in exacerbation frequency. One of the most frequent bacterial colonizers is Streptococcus pneumoniae. To mimic this aspect of COPD, a murine model of low-level pneumococcal colonization in the lung has been developed, in which S. pneumoniae persisted in the lungs for at least 28 days. From day 14 postinfection, bacterial numbers remained constant until at least 28 days postinfection, and animals showed no outward signs of disease. The bacterial presence correlated with a low-level inflammatory response that was localized to small foci across the left and inferior lobes of the lung. The cellular response was predominantly monocytic, and focal fibroplasia was observed at the airway transitional zones. Physiological changes in the lungs were investigated with a Forced Maneuvers system. This new model provides a means of study of a long-term pulmonary infection with a human pathogen in a rodent system. This is an excellent tool for the development of future models that mimic complex respiratory diseases such as COPD and asthma.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24866797      PMCID: PMC4136212          DOI: 10.1128/IAI.01623-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  The heterogeneity of chronic obstructive pulmonary disease.

Authors:  J A Wedzicha
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 3.  Do bacteria cause exacerbations of COPD?

Authors:  J V Hirschmann
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

4.  Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains.

Authors:  N A Gingles; J E Alexander; A Kadioglu; P W Andrew; A Kerr; T J Mitchell; E Hopes; P Denny; S Brown; H B Jones; S Little; G C Booth; W L McPheat
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 5.  Bacterial infection and the pathogenesis of COPD.

Authors:  S Sethi
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

6.  Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type.

Authors:  Aras Kadioglu; Sally Taylor; Francesco Iannelli; Gianni Pozzi; Tim J Mitchell; Peter W Andrew
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.

Authors:  S D Aaron; J B Angel; M Lunau; K Wright; C Fex; N Le Saux; R E Dales
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

8.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

9.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

Authors:  Yusheng Qiu; Jie Zhu; Venkata Bandi; Robert L Atmar; Keith Hattotuwa; Kay K Guntupalli; Peter K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  2003-07-11       Impact factor: 21.405

10.  Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.

Authors:  David E Briles; Susan K Hollingshead; James C Paton; Edwin W Ades; Lea Novak; Frederik W van Ginkel; William H Benjamin
Journal:  J Infect Dis       Date:  2003-07-14       Impact factor: 5.226

View more
  6 in total

1.  Repeated Exposure to Streptococcus pneumoniae Exacerbates Chronic Obstructive Pulmonary Disease.

Authors:  Xuxu Gou; Qiao Zhang; Sunil More; Gayan Bamunuarachchi; Yurong Liang; Faizan Haider Khan; Rachel Maranville; Emily Zuniga; Changzheng Wang; Lin Liu
Journal:  Am J Pathol       Date:  2019-06-18       Impact factor: 4.307

2.  Development for Clinical Use of a Multiplexed Immunoassay Using Sputum Samples for Streptococcus pneumoniae: a Non-Culture-Based Approach for Serotype-Specific Detection.

Authors:  Sun Jin Kim; Yoo Jung Jeong; Jong Hun Kim; Young Kyung Yoon; Jang Wook Sohn; Moon Hee Nahm; Min Ja Kim
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.

Authors:  Niharika Sharma-Chawla; Vicky Sender; Olivia Kershaw; Achim D Gruber; Julia Volckmar; Birgitta Henriques-Normark; Sabine Stegemann-Koniszewski; Dunja Bruder
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

4.  Cardiovascular changes after pneumonia in a dual disease mouse model.

Authors:  Benjamin Bartlett; Herbert P Ludewick; Shipra Verma; Vicente F Corrales-Medina; Grant Waterer; Silvia Lee; Girish Dwivedi
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

5.  A new model for non-typeable Haemophilus influenzae middle ear infection in the Junbo mutant mouse.

Authors:  Derek Hood; Richard Moxon; Tom Purnell; Caroline Richter; Debbie Williams; Ali Azar; Michael Crompton; Sara Wells; Martin Fray; Steve D M Brown; Michael T Cheeseman
Journal:  Dis Model Mech       Date:  2015-11-26       Impact factor: 5.758

6.  Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.

Authors:  Dilip C Badgujar; Anjali Anil; Angharad E Green; Manalee Vishnu Surve; Shilpa Madhavan; Alison Beckett; Ian A Prior; Barsa K Godsora; Sanket B Patil; Prachi Kadam More; Shruti Guha Sarkar; Andrea Mitchell; Rinti Banerjee; Prashant S Phale; Timothy J Mitchell; Daniel R Neill; Prasenjit Bhaumik; Anirban Banerjee
Journal:  PLoS Pathog       Date:  2020-11-20       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.